Ribosome assembly inhibitor based antibody drug conjugate - Hexagon Bio
Alternative Names: RAI-conjugated ADCs - Hexagon BioLatest Information Update: 23 Jan 2026
At a glance
- Originator Hexagon Bio
- Class Alkaloids; Antineoplastics; Camptothecins; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action DNA topoisomerase I inhibitors; Protein biosynthesis inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 22 Oct 2025 Preclinical trials in Solid tumours in USA (Parenteral)
- 22 Oct 2025 Pharmacokinetics, pharmacodynamics and adverse events data from preclinical trials in Solid tumours presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2025 (AACR-NCI-EORTC-2025)